Ultragenyx Pharmaceutical
RARE | NASDAQ
$15.90
-$0.18 (-1.12%)
At close: Nov 16, 2026, 4:00 PM ET
$15.85
-$0.05 (-0.31%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Ultragenyx Pharmaceutical Statistics
Key statistics explainedMarket Data
$1.62B
$2.54B
0.32
3.79M
102.1M
2.33%
N/A
NASDAQ
US90400D1081
Price Performance
9.3%
-39.1%
-34.3%
-30.9%
-51.1%
-60.2%
-79.5%
9.4%
-51.9%
-27.3%
-15.1%
Valuation
-3.06
86.63
-0.25
0.04
2.22
1.70
-4.31
-3.67
-2.81
-3.71
3.48
-5.63
-6.09
-5.75
-32.6%
-27.3%
-35.6%
Financial Health
$920M
$1.19B
$266M
$1.19B
1.40
1.25
-3.15
-2.84
-2.68
-0.37
-5.71
-5.66
3
Margins & Profitability
82.9%
-64.1%
-57.1%
-71.8%
-60.5%
-79.0%
18.5%
-30.6%
Returns
-44.1%
213.2%
-52.7%
-58.6%
-53.9%
Historical Growth (CAGR)
21.2%
15.2%
137.5%
10.9%
16.7%
-1.1%
-0.3%
3.8%
-7.2%
Analyst Forecasts
Buy
17
41.4%
18.4%
Feb 11, 2027
$2.39
-285.3%
$226.63M
9.5%
Fair Value Estimates
N/A
N/A
N/A
N/A
$23.00
44.7%
Cash Flow
$-436.83M
$-441.77M
$-577.06M
-$4.33
-$4.28
-59.8%
Income Statement
$730M
$605M
$-468M
$-417.22M
$-524M
-$5.19
$532.46K
$-382.2K
1,371
Add to Watchlist
Select watchlists to add or remove RARE